Skip to content

Retinitis Pigmentosa 68 C3810380

Published: July 22, 2026Updated: August 20, 2026

An inherited eye disorder causing progressive retinal degeneration and vision loss, often beginning with difficulty seeing in low light. Both eyes are typically affected. Treatment focuses on managing symptoms and supporting remaining vision.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central vision loss

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Peripheral vision loss (tunnel vision)

(ophthalmologic)

Photophobia (light sensitivity)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Retinal Pigment Epithelium Transplantation

Experimental surgical approach transplanting healthy RPE cells to replace damaged tissue supporting photoreceptor function. Currently available through clinical trials.

surgical
3

Ciliary Neurotrophic Factor (CNTF) Therapy

Intravitreal injection of CNTF to promote photoreceptor survival and potentially slow degeneration. Delivered through implanted refillable devices in some protocols.

medication

Additional treatment options

Mobility and Orientation Training

Specialized training by orientation and mobility specialists to develop skills for safe navigation, white cane use, and public transit utilization.

physical_therapy

Acoustic Stimulation Therapy

Non-invasive auditory training combined with visual stimulation to potentially enhance neural plasticity and preserve visual pathways through cross-modal sensory input.

complementary

Occupational Therapy Intervention

Comprehensive evaluation and training to maintain activities of daily living, including adaptive techniques for self-care, cooking, and medication management.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 68 C3810380?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa: the extended phenotype of RPE65 mutations. Ophthalmology Retina. 2022.

review2022
2

Stone EM, Allikmets R, Hirose E, et al. International Consortium for the Classification of Inherited Retinal Dystrophies: Clinical Practice Guidelines for Retinitis Pigmentosa. Br J Ophthalmol. 2021.

guideline2021
3

Cideciyan AV, Jacobson SG, Beltran WA, et al. Phase 2 Gene Therapy Trial for RPE65-Mediated Retinal Degeneration. JAMA Ophthalmol. 2020.

clinical_trial2020
4

Berger W, Kloeckener-Gruissem B, Neidhardt J. Molecular bases of visual transduction in inherited retinal diseases: a systematic review and meta-analysis. Prog Retin Eye Res. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 68 C3810380. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy